JENNIFER RACE: Open Payments
NPI 1609205418 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 22 payments from 9 companies in 2025. Trend: 2023 $302 · 2024 $462 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $113 |
| Collegium Pharmaceutical, Inc. | 6 | $106 |
| Boston Scientific Corporation | 2 | $61 |
| PFIZER INC. | 3 | $56 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| Bioventus LLC | 1 | $34 |
| ABBVIE INC. | 2 | $34 |
| Valinor Pharma, LLC | 1 | $19 |
| Nalu Medical, Inc. | 1 | $15 |
Products named: RELISTOR, XTAMPZA, NURTEC ODT, Artisan, JOURNAVX, Intracept, MOVANTIK, UBRELVY.
Industry payments across TX — which companies pay providers there.
